2023
DOI: 10.1016/j.bbagen.2022.130266
|View full text |Cite
|
Sign up to set email alerts
|

Biophysical and biochemical insights in the design of immunoassays

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3
2

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 59 publications
0
3
0
Order By: Relevance
“…Chemosensors 2023, 11, 66 8 of 18 7.4) with a concentration of 25 mM, where the sensor was kept for 5 min. Then, the sensor was further rinsed in 1.5 mL of deionized water to remove residual buffer solution and non-crosslinked omalizumab, and finally it was immersed in deionized water for impedance spectrum measurements.…”
Section: Impedance Spectroscopymentioning
confidence: 99%
See 1 more Smart Citation
“…Chemosensors 2023, 11, 66 8 of 18 7.4) with a concentration of 25 mM, where the sensor was kept for 5 min. Then, the sensor was further rinsed in 1.5 mL of deionized water to remove residual buffer solution and non-crosslinked omalizumab, and finally it was immersed in deionized water for impedance spectrum measurements.…”
Section: Impedance Spectroscopymentioning
confidence: 99%
“…Antibodies are either monoclonal or polyclonal. Monoclonal antibodies are produced by B cells that are clones of the same parent cell and are monovalent when they recognize the same antigen epitope [7]. This type of antibody is produced ex vivo in tissue culture.…”
Section: Introductionmentioning
confidence: 99%
“…However, rapid diagnostic production possesses major bottlenecks that inhibit rapid response. With each new disease, an entirely new LFA must be developed for a corresponding target, 2 requiring production of specific antibodies. The process of developing new antibodies can take 1–2 years and cost hundreds of millions of dollars.…”
Section: Introductionmentioning
confidence: 99%